Market Cap
$15.77B
Shares Outstanding
65.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 20, 2026
Round Lot
100
Locale
US
Day Open
$239.70
Day High
$248.58
Day Low
$237.22
Volume
591.6K
VWAP
$243.27
Prev Close
$239.77
Transactions
--
Acc. Volume
--
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Ascendis Pharma A/S Ordinary Share (ASND) closed the 2026-09-16 session at $248.37, up 3.59% versus the previous close (+8.60). The stock opened at $239.70 and traded between $237.22 and $248.58 during that session. Session trading volume was 592K shares. The volume-weighted average price (VWAP) is $243.27.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Ascendis Pharma A/S Ordinary Share has a market capitalization of $15.77 billion. ASND is listed on the XNAS exchange. The company employs approximately 1,189 people. The recorded listing date is 2026-04-20.
On this page you can find market ASND stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.